Dr Reddys Laboratories Share Price Today - Live Blog for October 20, 2025

Dr Reddys Laboratories Ltd observed a remarkable 0.06% surge in its share price and is presently trading at ₹1,282.00. The increased investor interest is driving this surge.

The stock of Dr Reddys Laboratories Ltd suffered a -0.02% decline, and it currently trades at ₹1,282.55 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd witnessed a -0.02% drop in its share price and is currently trading at ₹1,282.75. With the stock's PE at 18.2500 and the industry PE at 34.9860, investors are weighing their options.

Dr Reddys Laboratories Ltd's share price has fallen by -0.00%, a situation worth noting. At present, the stock is trading at ₹1,283.95. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.2500, while the industry PE ratio is 34.9860.

Dr Reddys Laboratories Ltd experienced a -0.31% dip in its share price and is currently trading at ₹1,282.00. The stock has a PE ratio of 18.2500, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has dropped by -0.31%, a development that warrants careful analysis. Presently trading at ₹1,282.00, investors are assessing whether this presents an opportunity or a risk.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.02%, with its current market value per share resting at ₹1,285.80. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd witnessed a substantial 0.05% increase in its share price and is currently trading at ₹1,285.50. This remarkable performance has caught the eye of investors.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.15% increase and currently trading at ₹1,284.80 per share. Investors are taking notice of this upward momentum.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.07% increase and currently trading at ₹1,282.95 per share. This upward trajectory is turning heads in the market.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.17% gain, with the share price now at ₹1,282.10. Notably, the stock's PE ratio stands at 18.2500, and its Return on Equity (ROE) is 16.8559%.

Following a noteworthy 0.20% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,281.00. When it comes to valuation, this stock has a PE ratio of 18.2500, with the industry PE ratio at 34.9860.

The stock of Dr Reddys Laboratories Ltd is facing a -0.05% decline and is currently trading at ₹1,278.50 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The share price of Dr Reddys Laboratories Ltd experienced a -0.19% slump and is currently trading at ₹1,278.85. While the stock maintains a PE ratio of 18.2500, the industry PE is 34.9860, raising questions about valuation.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.17%, reaching the current market price of ₹1,280.00. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.14%, reaching a current market price of ₹1,279.00. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

After a notable 0.59% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,279.60. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd experienced a -0.18% downturn in its share price, and it's currently trading at ₹1,276.75. This situation is generating interest among value investors who are evaluating the stock's potential.

Demonstrating a commendable 0.46% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,277.30. In terms of valuation, the stock maintains a PE ratio of 18.2500, while the industry PE ratio stands at 34.9860.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.25% gain, with the share price now at ₹1,270.40. Notably, the stock's PE ratio stands at 18.2500, and its Return on Equity (ROE) is 16.8559%.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.25%, reaching the current market price of ₹1,270.40. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd experienced a -0.06% downturn in its share price, and it's currently trading at ₹1,268.25. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.24%, reaching the current market price of ₹1,269.00. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd observed a -0.17% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,268.60. The stock has a PE ratio of 18.2500, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.17% in its share price, and it currently trades at ₹1,270.05 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.41%, and as of now, it's trading at ₹1,272.20 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd witnessed a substantial 0.39% increase in its share price and is currently trading at ₹1,267.95. This remarkable performance has caught the eye of investors.